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Introduction
Hepatocellular carcinoma (HCC) is a common and malignant tumor worldwide and is the third most lethal cancer, largely due to that HCC cells frequently invade vascular system at an early stage of the carcinogenesis and then metastasize through circulation to implant into distal organs [1] [2] [3] [4] [5] [6] [7] . Therefore, early detection and prevention of metastasis of HCC cells appear to be critical for developing effective therapy.
The past studies on the invasion and metastases of HCC cells have highlighted a pivotal role of circulating tumor cells (CTCs) in the process of cancer metastases [1] [2] [3] [4] [5] [6] [7] . CTCs are a particular population of cancer cells in the primary tumor. CTCs detach from the tumor mass and subsequently enter the blood circulation, from where they home to distal organs with a favorable environment for the tumor cells to stay and grow [1] [2] [3] [4] [5] [6] [7] . Since identification of CTCs in HCC may allow approaches to target these cells to inhibit cancer metastases, great efforts have been made to characterize CTCs in HCC [1] [2] [3] [4] [5] [6] [7] . Since only tumorigenic CTCs can form metastatic tumors in distal organs, CTCs often share some characteristics with cancer stem cells (CSCs), which are cancer cells that are responsible for cancer relapse and metastasis [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] . However, CSCs are not equivalent to CTCs, since not all CTCs form distal tumor, and not all CSCs undergo metastases [1] [2] [3] [4] [5] [6] [7] .
So far, among all CTC surface markers, CXCR4, which is a unique receptor for stromal cell -derived factor-1 (SDF-1), has been shown to be the most important one, and has been used to characterize CTCs in different cancers, including HCC [12] [13] [14] [15] [16] [17] [18] [19] [20] . However, CXCR4 appears to be not sufficient to purify real CTCs, since CXCR4 is expressed in a certain number of HCC cells, and they are not all CTCs. Hence, there is an urgent need for better characterizing CTCs in HCC.
Matrix Metalloproteinases (MMPs) are a family of zinc endopeptidases that digest and break down extracellular matrix during embryonic development, tissue remodeling and carcinogenesis. MMP26, also known as endometase or matrilysin-2, is a member of MMPs, and is expressed predominantly in the placenta and uterus. Recently, MMP26 has been detected in a number of cancers [21] [22] [23] [24] [25] [26] [27] [28] [29] . However, the role of MMP26 in the carcinogenesis of HCC has not been studied.
Here, we compared the HCC cells that form tumor sphere in culture to those that do not. We transduced HCC cells with a RFP reporter under MMP26 promoter and purified MMP26+CXCR4+ HCC cells. We examined tumor sphere formation, presence of tumor cells in the circulation and capability of developing metastatic tumor after transplantation of MMP26+CXCR4+ HCC cells into nude mice, compared to other populations in HCC. We found that sphere-forming HCC cells expressed high levels of MMP26 and CXCR4. MMP26+CXCR4+ HCC cells formed significantly more tumor spheres in culture, compared to MMP26-CXCR4-, MMP26-CXCR4+ or MMP26+CXCR4-HCC cells. Moreover, tumor cells were more frequently detected in the circulation when MMP26+CXCR4+ HCC cells were subcutaneously transplanted. Further, subcutaneous transplantation of MMP26+CXCR4+ HCC cells, but MMP26-CXCR4-, MMP26-CXCR4+ or MMP26+CXCR4-HCC cells significantly developed distal metastatic tumors.
Materials and Methods

Cell line culture and treatment
HepG2 is a human HCC line purchased from American Type Culture Collection (ATCC, Rockville, MD, USA), and was cultured in Dulbecco's modified Eagle's medium (DMEM, Invitrogen, Carlsbad, CA, USA) supplemented with 15% fetal bovine serum (FBS; Sigma-Aldrich, St Louis, MO, USA) in a humidified chamber with 5% CO 2 at 37 °C.
Transduction of HCC cells
We used pcDNA3.1-CAG-GFP, pcDNA3.1-CAG-RFP and pcDNA3.1-CAG-luciferase plasmids as backbones (all from Clontech, Mountain View, CA, USA). The GFP coding sequence was digested with Xhol and BamHI and subcloned with a 2A into a pcDNA3.1-CAG-luciferase, resulting in a construct named pCAG-luciferase-2A-GFP. The small 2A peptide sequences, when cloned between genes, allow for efficient, stoichiometric production of discrete protein products within a single vector through a novel "cleavage" event within the 2A peptide sequence. Human MMP26 promoter was cloned by PCR, using human genomic DNA as a template. MMP26 promoter was cloned into pcDNA3.1-CAG-RFP to replace CAG promoter, resulting in a construct named pMMP26-RFP. Finally, pCAG-luciferase-2A-GFP and pMMP26-RFP were connected into one construct. Sequencing was performed to confirm the correct orientation of the new plasmid. To generate lentiviral particles, HEK293T cells were seeded in a 100mm dish at 5X10 4 cells/cm 2 and cotransfected with 10µg of prepared plasmid and 5µg each of packaging plasmids (REV, pMDL and VSV-G) using Lipofectamine-2000 (Invitrogen). The supernatant containing lentiviral particles was collected 48 hours after transfection and filtered through a 0.45µm syringe filter. The viruses were purified using CsCl density centrifugation and then titered by a quantitative densitometric dot-blot assay. For cell transduction in vitro, HCC cells were seeded in 100mm plates at 1.5X10 4 cells/cm 2 one day prior to lentiviral infection. The lentiviral particles were added along with 10µg/ml polybrene (Sigma-Aldrich) to the cell culture at a multiplicity of infection (MOI) of 100 for 48 hours. Then the cells were washed twice with complete media and purified for transduced bells based on GFP by flow cytometry. Some MMP26+ cells are yellow due to co-expression of RFP and GFP.
Primary Tumor Sphere Culture
Purified tumor cells by flow cytometry were washed, acutely dissociated in oxygenated artificial cerebrospinal fluid and subject to enzymatic dissociation. Tumor cells were then resuspended in tumor sphere media (TSM) consisting of a serum-free DMEM, human recombinant EGF (20ng/ml; Sigma-Aldrich), bFGF (20ng/ml; Sigma-Aldrich), leukemia inhibitory factor (10ng/ml; Sigma-Aldrich) and N-acetylcysteine (60µg/ml; Sigma-Aldrich), and then plated at a density of 2X10 6 cells/60mm plate.
Analysis of CXCR4, RFP and GFP by flow cytometry
CXCR4, RFP and GFP-based cell analysis and sorting were performed by flow cytometry, after the cultured cells or cells from circulation were labeled with APC-conjugated CXCR4 antibodies (BectonDickinson Biosciences, San Jose, CA, USA). GFP and RFP were determined by direct fluorescence. Flow cytometry was performed using a FACSAria (Becton-Dickinson Biosciences) flow cytometer. Negative controls were applied to remove background noise and to confirm positive cells. Data were analyzed and quantified using Flowjo software (Flowjo LLC, Ashland, OR, USA).
Cell growth assay
For assay of cell growth, cells were seeded into 24 well-plate at 1X10 4 cells per well and subjected to a Cell Proliferation Kit (MTT, Roche, Indianapolis, IN, USA), according to the instruction of the manufacturer. The MTT assay is a colorimetric assay for assessing viable cell number, taking advantage that NADPH-dependent cellular oxidoreductase enzymes in viable cells reduce the tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to its insoluble formazan in purple readily being quantified by absorbance value (OD) at 570nm. Experiments were performed 5 times.
Quantitative real-time PCR (RT-qPCR)
Total RNA were extracted from cells with RNeasy kit (Qiagen, Hilden, Germany), for cDNA synthesis. Quantitative real-time PCR (RT-qPCR) was performed in duplicates with QuantiTect SYBR Green PCR Kit (Qiagen). All primers were purchased from Qiagen. Data were collected and analyzed with the Rotorgene software accompanying the PCR machine, using 2-△△Ct method for quantification of the relative mRNA expression levels. Values of genes were first normalized against α-tubulin, and then compared to controls.
Western blot
The protein was extracted from the HCC cells by RIPA buffer (Sigma, St Louis, USA) for Western Blot. The supernatants were collected after centrifugation at 1.2X10 gels. The separated proteins were then transferred to a PVDF membrane. The membrane blots were first probed with a primary antibody. After incubation with horseradish peroxidase-conjugated second antibody, autoradiograms were prepared using the enhanced chemiluminescent system to visualize the protein antigen. The signals were recorded using X-ray film. Primary antibodies were anti-CXCR4, anti-MMP26 and anti-α-tubulin (all purchased from Santa Cruz Biotechnology, Dallas, Texas, USA).
Mouse handling
All mouse experiments were approved by the Institutional Animal Care and Use Committee at the First Affiliated Hospital of Wenzhou Medical University (Animal Welfare Assurance). Mice were kept in a Specific pathogen fee (SPF) condition. Surgeries were performed in accordance with the Principles of Laboratory Care, supervised by a qualified veterinarian. All efforts were made to minimize pain and suffering. Female 10 week-old nude mice were used in the current study. Ten mice were analyzed in each experimental condition.
In vivo transplantations of tumor cells and bioluminescence imaging
Purified cells (10 6 ) were subcutaneously (s.c.) injected into the nude mice. The tumor growth after 4 months was monitored and quantified by luminescence levels. Bioluminescence was measured with the IVIS imaging system (Xenogen Corp., Alameda, CA, USA). All of the images were taken 10 minutes after intraperitoneal injection of luciferin (Sigma-Aldrich) of 150mg/kg body weight, as a 60-second acquisition and 10 of binning. During image acquisition, mice were sedated continuously via inhalation of 3% isoflurane. Image analysis and bioluminescent quantification was performed using Living Image software (Xenogen Corp).
Statistical analysis
All statistical analyses were carried out using the SPSS 18.0 statistical software package. All values in cell and animal studies are depicted as mean ± standard deviation and are considered significant if p < 0.05. All data were statistically analyzed using one-way ANOVA with a Bonferoni correction, followed by Fisher's Exact Test to compare two groups.
Results
HCC cells that form tumor sphere express high MMP26 and CXCR4
We used a human HCC cell line, HepG2, in our study. Since only tumorigenic CTCs form metastatic tumor in distal organs, we compared the HCC cells that form tumor sphere in culture (sphere+) to those that do not (sphere-) (Fig. 1A) . We found that sphere-forming HCC cells expressed significantly higher levels of MMP26 and CXCR4, by RT-qPCR (Fig. 1B) , and by Western blot (Fig. 1C) . These data prompted us to examine whether MMP26+CXCR4+ cells may be a specific subpopulation of CXCR4+ cells that are responsible for HCC distal metastases.
Labeling of HCC cells
To allow tracing tumor formation in living mice and isolation of MMP26+ tumor cells from mice, we transduced the HepG2 cells with a lentivirus carrying luciferase and GFP reporter under the control of a CAG promoter, and RFP reporter under MMP26 promoter ( Fig. 2A) . The transduced cells were purified based on GFP expression by flow cytometry. In culture, the transduced HCC cells were all green, and some cells appeared to be yellow (both red and green) due to co-expression of MMP26 (Fig. 2B) . These transduced HepG2 cells were re-analyzed by flow cytometry, showing that the yellow MMP26+ cells represent about 3.5% of total HCC cells (Fig. 2C) .
MMP26+CXCR4+ HCC cells grow much faster than negative populations
Since MMP26 has been recently shown to play a critical role in the carcinogenesis of some cancers, and since CXCR4 is a well-known CTC marker, we hypothesized MMP26+CXCR4+ HCC cells may be more purified CTCs than CXCR4+ cells in HCC. Thus, we separated HCC cell and about 0.4% cells were MMP26+CXCR4+ (Fig. 3A) . All 4 subpopulations of HCC cells were applied in a MTT assay to evaluate cell growth. We found that MMP26+CXCR4+ cells grew significantly faster than the other 3 subpopulations (Fig. 3B) . Moreover, when we challenged these 4 subpopulations of HCC cells with the tumor sphere media (TSM), we found that MMP26+CXCR4+ cells generated significantly more sphere-like structures than either MMP26-CXCR4+ or MMP26+CXCR4-cells, while MMP26-CXCR4-cells did not form spherelike structures at all (Fig. 3C) . Together, these data suggest that MMP26+CXCR4+ HCC cells are tumor-forming CSC-like cells.
MMP26+CXCR4+ HCC cells are CTCs
Then we examined the presence of GFP+ tumor cells in the circulation and capability of developing metastatic tumor after transplantation of these 4 subpopulations into nude mice. First, we checked the presence of GFP+ cells in circulation by flow cytometry, shown by representative flow charts of a negative sample from a mouse that received MMP26-CXCR4+ HCC cells (Fig. 4A) , and a positive sample from a mouse that received MMP26+CXCR4+ HCC cells (Fig. 4B) . While we hardly detected GFP+ circulatory cells in the mice that received either MMP26-CXCR4+, MMP26+CXCR4-, or MMP26-CXCR4-HCC cells, we did detect GFP+ circulatory cells in most of the mice that received MMP26+CXCR4+ HCC cells (Fig. 4C) . Moreover, we also evaluated the incidence of the development of tumors in distal organs [lung (Fig. 5A , blue arrow, mouse in the middle) and liver (Fig. 5A , red arrow, mouse in the right)], 4 months after transplantation. We found significant higher frequency for the formation of distal tumors in mice transplanted with MMP26+CXCR4+ HCC cells, compared to the other 3 subpopulations (Fig. 5B) . Together, these data suggest that MMP26+CXCR4+ cells are CTC cells in HCC. 
Discussion
Understanding the molecular regulation of HCC metastases is extremely important for improving the therapeutic outcome. Recently, the acknowledgement of the role of CTCs in cancer metastases sheds light on the development of innovative HCC-associated treatments. Efficient manipulation of CTCs requires precise characterization of this population among all cancer cells. To date, isolation of CTCs from HCC is mainly dependent on cell surface markers, among which the most important one is CXCR4. SDF-1/CXCR4 axis is a potential chemoattractant system for regulation of cell migration and homing, and plays an important and unique role in the regulation of stem/progenitor/cancer cell trafficking [30] [31] [32] [33] [34] . CXCR4 is known to be expressed on some tumor cells, which may metastasize to the organs that secrete/express SDF-1 [30] [31] [32] [33] [34] . SDF-1 exerts pleiotropic effects regulating metastasisassociated processes, including cancer cell locomotion, chemoattraction and adhesion, and tumor vascularization [30] [31] [32] [33] [34] . Although CXCR4 has been shown to substantially enrich the CTC population in various cancers, it is noteworthy that the purification of CTCs by the mere use of CXCR4 is not optimized and the enrichment of CTCs by CXCR4 is limited [12] [13] [14] [15] [16] [17] [18] . Thus, identification of additional CTC markers for HCC is highly needed.
Here, we used a human HCC cell line, HepG2, in our study. We have also performed similar analyses on other HCC cell lines and essentially got similar results. Thus, our findings should not be cell-line dependent. In order to trace tumor cells in living animals as well as identification of tumor cells from the circulation in receipt mice, we labeled the cells with both luciferase and GFP reporter under the control of a CAG promoter. In addition, the MMP26+ cells were labeled with RFP and thus appeared to be yellow due to co-expression of GFP and RFP. Since GFP construct is behind a 2A following luciferase, all sorted GFP+ cells should express luciferase. Thus, no luciferase-negative cells were transplanted.
We separated HCC cells into 4 subpopulations based on MMP26 and CXCR4 expression and in HCC cells, and only 0.4% cells were MMP26+CXCR4+, which was much lower, compared to MMP26-CXCR4+ cells. The tumorigenic property of MMP26+CXCR4+ cells were examined by cell growth assay and caner sphere-like structure formation. Next, we examined CTC properties of these 4 subpopulations, and only detected tumor cells in the circulation of mice that received MMP26+CXCR4+ HCC cells with high frequency. Interestingly, all detected GFP+ tumor cells were all red, suggesting that CTCs express MMP26, which is consistent with findings in our in vitro study. In addition, high-frequent tumor formation in distal organs was exclusively detected in mice that received MMP26+CXCR4+ HCC cells. Taken together, these experiments suggest that MMP26+CXCR4+ cells are CTC cells in HCC.
To our knowledge, our study should be the first one to use a combination of MMP26 and CXCR4 to characterize CTCs in HCC. Since a role of MMP26 has not been studied in HCC, our study suggests that MMP26 may play a potential role in HCC-related pathogenesis. Future studies may address the molecular pathways that activate MMP26 as well as be regulated by MMP26 in HCC. MMP26+CXCR4+ cells may be a promising therapeutic target for HCC.
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